应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INSM Insmed
休市中 07-19 16:00:00 EDT
75.97
+0.91
+1.21%
盘后
76.35
+0.38
+0.50%
18:26 EDT
最高
77.00
最低
74.34
成交量
126.07万
今开
75.66
昨收
75.06
日振幅
3.54%
总市值
122.48亿
流通市值
121.55亿
总股本
1.61亿
成交额
9,602万
换手率
0.79%
流通股本
1.60亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Insmed Incorporated盘中异动 股价大涨5.03%
自选股智能写手 · 07-12
Insmed Incorporated盘中异动 股价大涨5.03%
美国研究综述-Civitas Resources、GDS Holdings、Spirit Aerosystems
Reuters · 07-08
美国研究综述-Civitas Resources、GDS Holdings、Spirit Aerosystems
美国研究综述-Civitas Resources、GDS Holdings、Spirit Aerosystems
Reuters · 07-08
美国研究综述-Civitas Resources、GDS Holdings、Spirit Aerosystems
Insmed Incorporated盘中异动 大幅拉升5.21%报65.23美元
自选股智能写手 · 07-05
Insmed Incorporated盘中异动 大幅拉升5.21%报65.23美元
美国研究综述-AT&T, ATI, 加利福尼亚资源公司
Reuters · 07-01
美国研究综述-AT&T, ATI, 加利福尼亚资源公司
美国研究综述-花旗集团、耐克、特斯拉
Reuters · 06-20
美国研究综述-花旗集团、耐克、特斯拉
美国研究综述-花旗集团、耐克、特斯拉
Reuters · 06-20
美国研究综述-花旗集团、耐克、特斯拉
美国研究综述-和弦能源、PVH、Saia
Reuters · 06-06
美国研究综述-和弦能源、PVH、Saia
Insmed Incorporated盘中异动 快速上涨5.01%报57.81美元
自选股智能写手 · 06-03
Insmed Incorporated盘中异动 快速上涨5.01%报57.81美元
Insmed Incorporated盘中异动 下午盘急速下挫5.00%报54.13美元
自选股智能写手 · 06-01
Insmed Incorporated盘中异动 下午盘急速下挫5.00%报54.13美元
BUZZ-Insmed 大幅增资 6.5 亿美元后继续大涨
Reuters · 05-31
BUZZ-Insmed 大幅增资 6.5 亿美元后继续大涨
Insmed Incorporated盘中异动 早盘大幅拉升5.27%报56.37美元
自选股智能写手 · 05-30
Insmed Incorporated盘中异动 早盘大幅拉升5.27%报56.37美元
Insmed Inc-以每股51.50美元的公开价格对1260万股普通股进行承销公开发行
智通财经 · 05-30
Insmed Inc-以每股51.50美元的公开价格对1260万股普通股进行承销公开发行
Insmed Incorporated盘中异动 股价大涨5.01%报50.47美元
自选股智能写手 · 05-29
Insmed Incorporated盘中异动 股价大涨5.01%报50.47美元
巴克莱银行将Insmed目标价从40美元上调至63美元
智通财经 · 05-29
巴克莱银行将Insmed目标价从40美元上调至63美元
美国研究综述-欧特克、McKesson、Microstrategy
Reuters · 05-29
美国研究综述-欧特克、McKesson、Microstrategy
美国研究综述-欧特克、McKesson、Microstrategy
Reuters · 05-29
美国研究综述-欧特克、McKesson、Microstrategy
B of A Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由40.00美元调整至40.00美元。
智通财经 · 05-29
B of A Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由40.00美元调整至40.00美元。
Insmed大涨128% 肺功能药物试药结果积极
市场资讯 · 05-28
Insmed大涨128% 肺功能药物试药结果积极
Insmed Incorporated股价上涨125.09% 市值涨92.05亿美元
自选股智能写手 · 05-28
Insmed Incorporated股价上涨125.09% 市值涨92.05亿美元
加载更多
公司概况
公司名称:
Insmed
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。
发行价格:
--
{"stockData":{"symbol":"INSM","market":"US","secType":"STK","nameCN":"Insmed","latestPrice":75.97,"timestamp":1721419200000,"preClose":75.06,"halted":0,"volume":1260725,"hourTrading":{"tag":"盘后","latestPrice":76.35,"preClose":75.97,"latestTime":"18:26 EDT","volume":21316,"amount":1619326.15,"timestamp":1721428011046},"delay":0,"floatShares":160000000,"shares":161225907,"eps":-5.212249,"marketStatus":"休市中","marketStatusCode":7,"change":0.91,"latestTime":"07-19 16:00:00 EDT","open":75.66,"high":77.0001,"low":74.34,"amount":96015832.63450001,"amplitude":0.03544,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.212249,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721635200000},"adr":0,"listingDate":959832000000,"adjPreClose":75.06,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":74.73,"preClose":75.06,"latestTime":"09:28 EDT","volume":479,"amount":35555.491735999996,"timestamp":1721395680068},"postHourTrading":{"tag":"盘后","latestPrice":76.35,"preClose":75.97,"latestTime":"18:26 EDT","volume":21316,"amount":1619326.15,"timestamp":1721428011046},"volumeRatio":0.4567549298085174,"impliedVol":0.5045,"impliedVolPercentile":0.3492},"requestUrl":"/m/hq/s/INSM","defaultTab":"news","newsList":[{"id":"2450390327","title":"Insmed Incorporated盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450390327","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450390327?lang=zh_cn&edition=full","pubTime":"2024-07-12 03:28","pubTimestamp":1720726139,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日03时28分,Insmed Incorporated股票出现异动,股价快速上涨5.03%。Insmed Incorporated股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、Kazia Therapeutics Limited、Neximmune, Inc.涨幅较大,Neximmune, Inc.、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为2378.21%、712.93%、685.55%,振幅较大的相关个股有Neximmune, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Biodexa Pharmaceuticals Plc,振幅分别为205.40%、149.14%、101.95%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712032859941f6598&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712032859941f6598&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM"],"gpt_icon":0},{"id":"2449741743","title":"美国研究综述-Civitas Resources、GDS Holdings、Spirit Aerosystems","url":"https://stock-news.laohu8.com/highlight/detail?id=2449741743","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449741743?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:48","pubTimestamp":1720421334,"startTime":"0","endTime":"0","summary":" 路透7月8日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Civitas Resources、GDS Holdings 和 Spirit Aerosystems。* Interactive Brokers Group Inc :杰富瑞将目标价从138美元上调至150美元 * LPL Financial Holdings Inc :杰富瑞将预测价值从322美元上调至334美元 * Spirit Aerosystems :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CIVI","AA","PSTL","SEDG","BK4581","LU0109394709.USD","FFWM","X","IBKR","LU2087625088.SGD","BK4589","BK4520","HCC","LU1363072403.SGD","BK4223","LU0971096721.USD","LU2249611893.SGD","SG9999001077.SGD","LU1201861249.SGD","LU1804176565.USD","BK4563","LU0011850046.USD","LU1064131342.USD","BK4526","LU0980610538.SGD","RJF","BK4504","BK4213","LU0312595415.SGD","LU2265009873.SGD","GDS","BK4585","LU1861217088.USD","BK4588","BK4529","IE0034235188.USD","BK4211","LPLA","LU1861220207.SGD","VSTM","BK4139","BK4516","BK4561","LU1668664300.SGD","BK4505","SPR","BK4194","BTU","INSM","SCHW"],"gpt_icon":0},{"id":"2449417457","title":"美国研究综述-Civitas Resources、GDS Holdings、Spirit Aerosystems","url":"https://stock-news.laohu8.com/highlight/detail?id=2449417457","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449417457?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:48","pubTimestamp":1720421334,"startTime":"0","endTime":"0","summary":" 路透7月8日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Civitas Resources、GDS Holdings 和 Spirit Aerosystems。* Interactive Brokers Group Inc :杰富瑞将目标价从138美元上调至150美元 * LPL Financial Holdings Inc :杰富瑞将预测价值从322美元上调至334美元 * Spirit Aerosystems :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AA","LU1804176565.USD","LPLA","LU0971096721.USD","PSTL","SPR","BK4563","HCC","BK4585","BK4223","SEDG","IE0034235188.USD","BK4589","LU2087625088.SGD","BK4504","BK4505","BTU","BK4194","BK4529","LU0109394709.USD","FFWM","BK4561","LU1064131342.USD","X","SCHW","LU0011850046.USD","CIVI","BK4588","LU0980610538.SGD","BK4213","LU1363072403.SGD","BK4520","INSM","LU1668664300.SGD","LU1201861249.SGD","LU1861217088.USD","VSTM","GDS","BK4211","BK4139","BK4581","BK4516","LU2265009873.SGD","LU2249611893.SGD","SG9999001077.SGD","LU0312595415.SGD","IBKR","LU1861220207.SGD","BK4526","RJF"],"gpt_icon":0},{"id":"2449260618","title":"Insmed Incorporated盘中异动 大幅拉升5.21%报65.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449260618","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449260618?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:31","pubTimestamp":1720186310,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时31分,Insmed Incorporated股票出现异动,股价急速拉升5.21%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为0.39%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。消息层面,截至21时31分,《摩根大通维持Insmed买入评级》资讯为影响Insmed Incorporated的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213150941f4704&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213150941f4704&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM"],"gpt_icon":0},{"id":"2448952768","title":"美国研究综述-AT&T, ATI, 加利福尼亚资源公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2448952768","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448952768?lang=zh_cn&edition=full","pubTime":"2024-07-01 15:23","pubTimestamp":1719818605,"startTime":"0","endTime":"0","summary":" 路透7月1日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 AT&T、ATI 和加州资源公司。要闻 * AT&T Inc :摩根大通将其股票列入美国分析师关注名单 * ATI Inc :摩根大通将其股票从美国分析师关注名单中删除 * 加州资源公司 :Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4589","KNTK","LU1621767737.EUR","ATI","LU0321505439.SGD","LU1621768115.EUR","BK4505","LU0053671581.USD","LU2065732104.USD","NOG","RCKT","BK4507","BK4585","BK4562","BK4144","SM","BK4588","TSHA","CHRS","APLS","BK4207","BK4213","LU1621767810.EUR","T","WBA","INSM","RIVN","CENT","BK4211","IE00B19Z3581.USD","BK4187","EQT","BK4196","SPB","NKLA","LU0889565916.HKD","ILMN","LU0109394709.USD","BK4018","CRC","BK4561","OVV","BK4139","IE00BSNM7G36.USD","PTCT","ACCD","IE00B7SZLL34.SGD","FCNCA","HXL","ELAN"],"gpt_icon":0},{"id":"2444597263","title":"美国研究综述-花旗集团、耐克、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2444597263","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444597263?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:03","pubTimestamp":1718866998,"startTime":"0","endTime":"0","summary":" 路透6月20日 - 华尔街证券分析师周四调整了对花旗集团、耐克和特斯拉等多家美国上市公司的评级和目标价。* 花旗集团 :KBW 将目标价从 66 美元上调至 69 美元 * Lennar Corp :Evercore ISI 将目标价从 238 美元下调至 237 美元 * 耐克公司 :巴克莱将目标价从114美元下调至109美元 * 特斯拉 :加拿大皇家银行将目标价从293美元下调至227美元 以下是路透周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU2023250504.SGD","KBH","LU1974910355.USD","LU0056508442.USD","ENPH","C","LU1861558580.USD","LU2756315318.SGD","INSM","LU1064131342.USD","LU2756315664.SGD","LU2087621335.USD","BK4147","BK4566","NEE","IE00BMG7P926.USD","LU1720051017.SGD","BFH","LU2098885051.SGD","LU2063271972.USD","LU0943347566.SGD","BK4207","ZIP","LU0052756011.USD","SAGE","IE00BWXC8680.SGD","BK4144","TSLL","TSLA","LU2637428348.USD","IE00BJTD4V19.USD","LU0198837287.USD","NKE","BK4527","BK4146","LU2326559502.SGD","LU1917777945.USD","IE00BD4GTV84.USD","BK4551","BK4099","BK4590","BK4592","LEN","BK4550","LU1303367103.USD","STZ","BK4561","ET","LU1668664300.SGD"],"gpt_icon":0},{"id":"2444263518","title":"美国研究综述-花旗集团、耐克、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2444263518","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444263518?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:03","pubTimestamp":1718866998,"startTime":"0","endTime":"0","summary":" 路透6月20日 - 华尔街证券分析师周四调整了对花旗集团、耐克和特斯拉等多家美国上市公司的评级和目标价。* 花旗集团 :KBW 将目标价从 66 美元上调至 69 美元 * Lennar Corp :Evercore ISI 将目标价从 238 美元下调至 237 美元 * 耐克公司 :巴克莱将目标价从114美元下调至109美元 * 特斯拉 :加拿大皇家银行将目标价从293美元下调至227美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2756315664.SGD","LU0056508442.USD","KBH","BK4144","LU0198837287.USD","IE00BMG7P926.USD","LU1917777945.USD","ET","LU2087621335.USD","STZ","BK4146","NEE","LU2326559502.SGD","LU2637428348.USD","LU0052756011.USD","BK4590","BFH","BK4207","ENPH","IE00BJTD4V19.USD","LU2098885051.SGD","C","LU2063271972.USD","BK4504","BK4551","IE00BWXC8680.SGD","ZIP","LU1668664300.SGD","BK4566","BK4527","NKE","BK4592","BK4550","BK4099","LU0943347566.SGD","LU1303367103.USD","TSLA","TSLL","LU1064131342.USD","SAGE","LU2756315318.SGD","LU1974910355.USD","LU2023250504.SGD","INSM","LU1861558580.USD","BK4561","IE00BD4GTV84.USD","LU1720051017.SGD","LEN","BK4147"],"gpt_icon":0},{"id":"2441661207","title":"美国研究综述-和弦能源、PVH、Saia","url":"https://stock-news.laohu8.com/highlight/detail?id=2441661207","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441661207?lang=zh_cn&edition=full","pubTime":"2024-06-06 15:13","pubTimestamp":1717658029,"startTime":"0","endTime":"0","summary":" 路透6月6日 - 华尔街证券分析师周四调整了对 Chord Energy、PVH 和 Saia 等几家美国上市公司的评级和目标价。* 好市多批发公司 :奥本海默将目标价从850美元上调至905美元 * PVH Corp :巴克莱将目标价从149美元上调至154美元 * Saia Inc :TD Cowen将目标价从473美元上调至475美元 * Take-Two Interactive Software Inc :摩根大通将目标价从180美元上调至200美元 以下是路透周四报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FERG","BK4505","APH","MD","CRWD","CHPT","BASE","INSM","LU2286300806.USD","OLLI","SSRM","IE00B894F039.SGD","IE00BZ1G4Q59.USD","LU1951200564.SGD","BK4211","SNOW","PBR","HPE","LU1559883803.SGD","ILMN","HALO","LU0498741114.HKD","WMT","XYL","PVH","SMAR","LU1951198990.SGD","LAAC","LUCD","BK4504","BK4542","VBNK","LU0566484027.USD","UNFI","CHRD","COST","LU0289960550.SGD","VIR","CXM","DLTR","VRNT","SITE","SAIA","BK4581","PAVM","LU2125154935.USD","LU2092937221.SGD","SHC","LU2272731782.SGD","TTWO"],"gpt_icon":0},{"id":"2440695494","title":"Insmed Incorporated盘中异动 快速上涨5.01%报57.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440695494","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440695494?lang=zh_cn&edition=full","pubTime":"2024-06-03 23:01","pubTimestamp":1717426881,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日23时01分,Insmed Incorporated股票出现异动,股价快速上涨5.01%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为1.32%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。消息层面,截至23时01分,《Form 144 | Insmed高管拟出售4.24万股股份,价值约243.74万美元》资讯为影响Insmed Incorporated的重要信息。此外,Flammer Martina M.D.自2024年5月14日起至今合共已减持该公司11.91万股股份,总价值约553.45万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603230121aef31d92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603230121aef31d92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","BK4139"],"gpt_icon":0},{"id":"2440945898","title":"Insmed Incorporated盘中异动 下午盘急速下挫5.00%报54.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440945898","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440945898?lang=zh_cn&edition=full","pubTime":"2024-06-01 01:49","pubTimestamp":1717177744,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日01时49分,Insmed Incorporated股票出现异动,股价快速下跌5.00%。截至发稿,该股报54.13美元/股,成交量365.27万股,换手率2.24%,振幅5.97%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为0.43%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。消息层面,截至01时49分,《B of A Securities:维持Insmed评级,由买入调整至买入评级, 目标价由40.00美元调整至40.00美元。》资讯为影响Insmed Incorporated的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601014904af8b6bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601014904af8b6bb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","BK4139"],"gpt_icon":0},{"id":"2439622921","title":"BUZZ-Insmed 大幅增资 6.5 亿美元后继续大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2439622921","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439622921?lang=zh_cn&edition=full","pubTime":"2024-05-31 00:20","pubTimestamp":1717086037,"startTime":"0","endTime":"0","summary":" 5月30日 - ** 周四,Insmed 股价上涨9.7%,报58.73美元,连续第三个交易日上涨,原因是该生物制药公司筹集的资金超过了目标金额。** 该公司称其罕见肺病药物 brensocatib 在后期研究中取得成功,INSM 股价周二从 22 美元上涨了一倍多,收于 48.06 美元,创 23 年新高。 ** 周二收盘后,该公司推出了 5 亿美元的股票发行计划** 如果 brensocatib 获批,该公司计划将募集资金净额用于继续开展与 brensocatib 相关的研发和商业化活动,同时继续商业化其另一种肺病药物 Arikayce。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","LU0106831901.USD","BK4533","IE00BSNM7G36.USD","LU1668664300.SGD","BK4127","INSM","BK4504","BK4588","BUZZ","BK4550","BK4585","BK4552","BK4139"],"gpt_icon":1},{"id":"2439642553","title":"Insmed Incorporated盘中异动 早盘大幅拉升5.27%报56.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439642553","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439642553?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:30","pubTimestamp":1717075850,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时30分,Insmed Incorporated股票出现异动,股价快速上涨5.27%。截至发稿,该股报56.37美元/股,成交量60.5749万股,换手率0.41%,振幅0.60%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为0.01%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。消息层面,截至21时30分,《B of A Securities:维持Insmed评级,由买入调整至买入评级, 目标价由40.00美元调整至40.00美元。》资讯为影响Insmed Incorporated的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213050aef28fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213050aef28fe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","BK4139"],"gpt_icon":0},{"id":"2439903645","title":"Insmed Inc-以每股51.50美元的公开价格对1260万股普通股进行承销公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=2439903645","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439903645?lang=zh_cn&edition=full","pubTime":"2024-05-30 20:16","pubTimestamp":1717071407,"startTime":"0","endTime":"0","summary":"Insmed Inc-以每股51.50美元的公开价格对1260万股普通股进行承销公开发行","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302016519f054cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302016519f054cb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INSM"],"gpt_icon":0},{"id":"2439712345","title":"Insmed Incorporated盘中异动 股价大涨5.01%报50.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439712345","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439712345?lang=zh_cn&edition=full","pubTime":"2024-05-29 23:18","pubTimestamp":1716995908,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日23时18分,Insmed Incorporated股票出现异动,股价急速拉升5.01%。截至发稿,该股报50.47美元/股,成交量432.691万股,换手率2.91%,振幅8.61%。Insmed Incorporated股票所在的生物技术行业中,整体跌幅为1.10%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。消息层面,截至23时18分,《B of A Securities:维持Insmed评级,由买入调整至买入评级, 目标价由40.00美元调整至40.00美元。》资讯为影响Insmed Incorporated的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529231828941eaec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529231828941eaec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","BK4139"],"gpt_icon":0},{"id":"2439460375","title":"巴克莱银行将Insmed目标价从40美元上调至63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439460375","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439460375?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:16","pubTimestamp":1716977803,"startTime":"0","endTime":"0","summary":"Insmed, Inc.:巴克莱银行将目标价从40美元上调至63美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405291816459eff1edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405291816459eff1edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM"],"gpt_icon":0},{"id":"2439590147","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590147","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590147?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":" 路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括欧特克、麦科森和微策略。要闻 * 模拟器件公司 :雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc :贝尔德将目标价从296美元下调至289美元 * Cencora Inc :贝雅将目标价从277美元上调至280美元 * McKesson Corp :贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc :Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IKNA","LU0006061336.USD","LYV","TKO","BAH","BK4528","PDFS","LU0310799852.SGD","ADI","BK4588","STZ","AKTS","PLMR","MNRO","IE00B7SZL793.SGD","CAH","AGIO","MCK","CASY","BK4139","BK4529","ADSK","LU0323240290.USD","LU1244550221.USD","MYRG","AAL","RLJ","HRT","TAP","CRVO","MSTR","NAPA","IBTX","INSM","TGI","BK4585","UAL","SAGE","BK4130","DOMO","RSI","LU1978683503.SGD","CAVA","IE00B19Z4B17.USD","MNMD","BK4214","BK4561","CTRE","COR","LU1642822529.SGD"],"gpt_icon":0},{"id":"2439590142","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590142","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590142?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":" 路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括欧特克、麦科森和微策略。要闻 * 模拟器件公司 :雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc :贝尔德将目标价从296美元下调至289美元 * Cencora Inc :贝雅将目标价从277美元上调至280美元 * McKesson Corp :贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc :Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADSK","BK4561","MNMD","RSI","PDFS","CAH","LU1244550221.USD","INSM","LU0310799852.SGD","AKTS","BK4585","BK4214","IBTX","MYRG","NAPA","BK4529","UAL","CASY","CTRE","LU1642822529.SGD","BAH","BK4588","IKNA","DOMO","TAP","LYV","RLJ","TGI","MNRO","AGIO","TKO","MSTR","COR","STZ","BK4528","MCK","ADI","SAGE","IE00B7SZL793.SGD","LU1978683503.SGD","HRT","PLMR","BK4130","LU0323240290.USD","CAVA","LU0006061336.USD","CRVO","AAL","IE00B19Z4B17.USD","BK4139"],"gpt_icon":0},{"id":"2439583297","title":"B of A Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由40.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439583297","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439583297?lang=zh_cn&edition=full","pubTime":"2024-05-29 01:15","pubTimestamp":1716916553,"startTime":"0","endTime":"0","summary":"B of A Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由40.00美元调整至40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290115559efb0039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290115559efb0039&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM"],"gpt_icon":0},{"id":"2438955303","title":"Insmed大涨128% 肺功能药物试药结果积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2438955303","media":"市场资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438955303?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:46","pubTimestamp":1716903960,"startTime":"0","endTime":"0","summary":"格隆汇5月28日|专注于肺部疾病的生物制药公司Insmed(INSM)股价上涨128%,创2017年以来最大盘中涨幅,报50.10美元,创2001年以来盘中新高。该公司宣布,其口服候选药在第三阶段临床试验中实现关键目标,缓和肺部疾病的症状。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:郭明煜","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/usstock/c/2024-05-28/doc-inawvcip2464756.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-05-28/doc-inawvcip2464756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["INSM","BK4139"],"gpt_icon":0},{"id":"2438372977","title":"Insmed Incorporated股价上涨125.09% 市值涨92.05亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438372977","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438372977?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:32","pubTimestamp":1716903142,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时32分,Insmed Incorporated股票出现异动,股价快速上涨125.09%。Insmed Incorporated股票所在的生物技术行业中,整体跌幅为0.86%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。消息层面,截至21时32分,《Insmed Inc:计划迅速推进美国监管备案预计将于2025年中期在美国上市尚待批准》资讯为影响Insmed Incorporated的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282132229ef99e42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282132229ef99e42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INSM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insmed.com","stockEarnings":[{"period":"1week","weight":-0.0096},{"period":"1month","weight":0.1584},{"period":"3month","weight":2.1238},{"period":"6month","weight":1.7132},{"period":"1year","weight":2.5683},{"period":"ytd","weight":1.4514}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.07032},{"month":2,"riseRate":0.393939,"avgChangeRate":0.079495},{"month":3,"riseRate":0.382353,"avgChangeRate":-0.053522},{"month":4,"riseRate":0.411765,"avgChangeRate":0.050726},{"month":5,"riseRate":0.411765,"avgChangeRate":0.070481},{"month":6,"riseRate":0.529412,"avgChangeRate":0.014908},{"month":7,"riseRate":0.470588,"avgChangeRate":0.00387},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.03265},{"month":9,"riseRate":0.575758,"avgChangeRate":0.033632},{"month":10,"riseRate":0.424242,"avgChangeRate":-0.023724},{"month":11,"riseRate":0.636364,"avgChangeRate":0.104946},{"month":12,"riseRate":0.484848,"avgChangeRate":0.050703}],"exchange":"NASDAQ","name":"Insmed","nameEN":"Insmed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Insmed,INSM,Insmed股票,Insmed股票老虎,Insmed股票老虎国际,Insmed行情,Insmed股票行情,Insmed股价,Insmed股市,Insmed股票价格,Insmed股票交易,Insmed股票购买,Insmed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}